Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
My Portfolio
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Got $10,000? 3 Hot Stocks to Buy That Could Make You a Fortune
↗
November 10, 2026
Via
The Motley Fool
Tickers
AGLT
AMZN
ASX:SFC
GRAL
GXO
MELI
Exposures
Product Safety
TriSalus (TLSI) Q3 2026 Earnings Call Transcript
↗
November 10, 2026
Via
The Motley Fool
Topics
Earnings
Tickers
TLSI
Exposures
Financial
Product Safety
Scholar Rock (SRRK) Q3 2026 Earnings Call Transcript
↗
November 10, 2026
Via
The Motley Fool
Topics
Earnings
Tickers
SRRK
Exposures
Financial
Product Safety
FDA Rejects NovoCure’s Optune Mya for Lung Cancer Brain Metastases. Here's What It Means for Investors.
↗
November 10, 2026
Via
The Motley Fool
Tickers
NVCR
Exposures
Product Safety
What Legend Biotech (LEGN) Said on Its Q3 Earnings Call
↗
November 10, 2026
Via
MarketBeat
Topics
Earnings
Tickers
LEGN
Exposures
Financial
Product Safety
PEMEC’s Apprentice-Turned-CEO Backs Hull Talent With 18,000 Sq Ft Expansion
November 10, 2026
Via
Press Release Distribution Service
Topics
Product Recall
Exposures
Legal
Product Safety
What Hemab Therapeutics (COAG) Said on Its Q3 Earnings Call
↗
November 10, 2026
Via
MarketBeat
Topics
Earnings
Tickers
COAG
Exposures
Financial
Product Safety
MissionIRNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Publishes Phase 1a Glioblastoma Data, Advances LP-184 Combination Therapy Toward Phase 1b/2a Trial
November 10, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
Tickers
LTRN
Exposures
Artificial Intelligence
Product Safety
BioMedNewsBreaks – NanoViricides (NYSE American: NNVC) Advances NV-387 Measles Treatment Toward Phase II Clinical Trials
November 10, 2026
Via
Investor Brand Network
Topics
Intellectual Property
Tickers
NNVC
Exposures
COVID-19
Intellectual Property
Product Safety
Vir Biotechnology Hepatitis Delta Treatment Meets Phase III Goals, With 79% Virus-Free at Week 48
↗
November 10, 2026
Via
MarketBeat
Tickers
VIR
Exposures
Product Safety
OS Therapies Initiates U.K. MHRA Conditional Marketing Authorisation Application for Herlystic (OST-HER2) in the Prevention or Delay of Recurrence in Fully Resected, Pulmonary Metastatic Osteosarcoma
November 10, 2026
Via
Newsfile
Tickers
OSTX
Exposures
Product Safety
John W Hardy Announces Divorce Recovery Coaching Focused on Helping Men Rebuild Life, Identity, and Confidence
November 10, 2026
Via
Press Release Distribution Service
Topics
Product Recall
Exposures
Legal
Product Safety
Professional Guide to Buy Airtight Glass Food Containers
November 10, 2026
Via
Worldnewswire
Exposures
Product Safety
Xenon (XENE) Q3 2026 Earnings Call Transcript
↗
November 10, 2026
Via
The Motley Fool
Topics
Earnings
Tickers
XENE
Exposures
Financial
Product Safety
Trevi Therapeutics (TRVI) Q3 2026 Earnings Call Transcript
↗
November 10, 2026
Via
The Motley Fool
Topics
Earnings
Intellectual Property
Tickers
TRVI
Exposures
Financial
Intellectual Property
Product Safety
OCUL Q3 2026 deep dive: AXPAXLI NDA submission and clinical strategy drive focus
November 10, 2026
Via
StockStory
Tickers
OCUL
Exposures
Product Safety
Axsome Therapeutics Tops $1 Billion Revenue Run Rate as AUVELITY Sales Surge
↗
November 09, 2026
Via
MarketBeat
Tickers
AXSM
Exposures
Product Safety
Definium (DFTX) Q3 2026 Earnings Call Transcript
↗
November 09, 2026
Via
The Motley Fool
Topics
Earnings
Tickers
DFTX
Exposures
Financial
Product Safety
OraSure Technologies Q3 Earnings Call Highlights
↗
November 09, 2026
Via
MarketBeat
Topics
Earnings
Tickers
OSUR
Exposures
Financial
Product Safety
What Coherus Oncology (CHRS) Said on Its Q3 Earnings Call
↗
November 09, 2026
Via
MarketBeat
Topics
Earnings
Tickers
CHRS
Exposures
Financial
Product Safety
What Definium Therapeutics (DFTX) Said on Its Q3 Earnings Call
↗
November 09, 2026
Via
MarketBeat
Topics
Earnings
Tickers
DFTX
Exposures
Financial
Product Safety
SIGA (SIGA) Q3 2026 Earnings Call Transcript
↗
November 09, 2026
Via
The Motley Fool
Topics
Earnings
Tickers
SIGA
Exposures
Financial
Product Safety
Home Age Fit Addresses Adult Bed Rails Safety Following October Federal Recalls and Warning
November 09, 2026
Via
Press Advantage
Topics
Product Recall
Exposures
Legal
Product Safety
Abeona Therapeutics (ABEO) Q3 2026 Earnings Call Transcript
↗
November 09, 2026
Via
The Motley Fool
Topics
Earnings
Tickers
ABEO
Exposures
Financial
Product Safety
Why ImmunityBio Stock Dropped 15% After Earnings Despite 53% Sales Growth. Is IBRX Now a Buy?
↗
November 09, 2026
Via
The Motley Fool
Exposures
Product Safety
What Turning Point Brands (TPB) Said on Its Q3 Earnings Call
↗
November 09, 2026
Via
MarketBeat
Topics
Earnings
Tickers
TPB
Exposures
Financial
Product Safety
NeurAxis (NRXS) Q3 2026 Earnings Call Transcript
↗
November 09, 2026
Via
The Motley Fool
Topics
Earnings
Tickers
NRXS
Exposures
Financial
Product Safety
Vance Thompson Vision Sioux Falls Highlights Dr. John Berdahl's 50,000+ Eye Surgeries and Pioneering Glaucoma Research
November 09, 2026
Via
Press Advantage
Exposures
Product Safety
Beta Bio: 3 Key Takeaways for Long-Term Investors
↗
November 09, 2026
Via
The Motley Fool
Topics
Earnings
Tickers
BBNX
Exposures
Financial
Product Safety
What Ocular Therapeutix (OCUL) Said on Its Q3 Earnings Call
↗
November 09, 2026
Via
MarketBeat
Topics
Earnings
Tickers
OCUL
Exposures
Financial
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.